Cercare Perfusion
Cercare Medical
Product specifications |
Information source:
Vendor
Last updated: Nov. 29, 2022 |
General | |
---|---|
Product name | Cercare Perfusion |
Company | Cercare Medical |
Subspeciality | Neuro |
Modality | CT, MR |
Disease targeted | Stroke, brain oncology, Alzheimer’s dementia, carotid artery stenosis, and adrenoleukodystrophy. |
Key-features | Automated post-processing, leakage correction, automatic coregistration, automatic motion correction, easy-to-read perfusion maps. |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps) |
Data characteristics | |
Population | All with suspicion of neurological diseases involving vascular pathology |
Input | CTP, MRI (DCE/DSC), MRI DWI |
Input format | DICOM |
Output | Heatmap overlay |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker) |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 11-2019 |
Distribution channels | syngo.via OpenApps, Sectra Amplifier Store, Blackford, Wellbeing Software, Arterys, Viz Platform, Eureka Clinical AI |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |